Bio-Techne (TECH) Research & Development (2009 - 2026)

Bio-Techne's Research & Development history runs 18 years deep, the most recent figure standing at $23.5 million for Q1 2026.

• On a quarterly basis, Research & Development fell 4.57% year-over-year to $23.5 million in Q1 2026; TTM through Mar 2026 was $96.9 million, a 0.62% decrease from a year earlier, with the FY2025 full-year figure at $99.5 million, up 2.93% from the prior year.
• Research & Development rose to $23.5 million in Q1 2026 per TECH's latest filing, from $23.1 million in the prior quarter.
• Across five years, Research & Development topped out at $26.0 million in Q2 2025 and bottomed at $21.7 million in Q1 2022.
• The 5-year median for Research & Development is $23.9 million (2024), against an average of $23.8 million.
• Across the five-year window, Research & Development increased 27.5% in 2022 and retreated 7.56% in 2025, its largest moves.
• Year by year, Research & Development stood at $22.5 million in 2022, then grew by 2.03% to $22.9 million in 2023, then grew by 9.16% to $25.0 million in 2024, then slipped by 7.56% to $23.1 million in 2025, then increased by 1.43% to $23.5 million in 2026.
• Per Business Quant, the three latest TECH Research & Development figures stand at $23.5 million (Q1 2026), $23.1 million (Q4 2025), and $24.2 million (Q3 2025).